Cyclin-dependent kinases (cdks) and the DNA damage response: rationale for cdk inhibitor–chemotherapy combinations as an anticancer strategy for solid tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cyclin-dependent kinases (cdks) and the DNA damage response: rationale for cdk inhibitor–chemotherapy combinations as an anticancer strategy for solid tumors

Published:2010-10-09 Issue:11 Volume:14 Page:1199-1212
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Johnson Neil,Shapiro Geoffrey I

Publisher

Informa Healthcare

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14728222.2010.525221

Reference124 articles.

1. A family of human cdc2-related protein kinases.

2. Cyclin-Dependent Kinase Pathways As Targets for Cancer Treatment

3. Cell cycle, CDKs and cancer: a changing paradigm

4. A DNA Damage Checkpoint Meets the Cell Cycle Engine

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of specific CDKs in regulating DNA damage repair responses and replication stress;Current Opinion in Pharmacology;2024-12

2. Specific small interfering RNAs (siRNAs) for targeting the metastasis, immune responses, and drug resistance of colorectal cancer cells (CRC);International Immunopharmacology;2024-10

3. Advances in breast cancer research using CRISPR/Cas9 system;Nano Select;2024-05-26

4. CDK-independent role of D-type cyclins in regulating DNA mismatch repair;Molecular Cell;2024-04

5. CDK9-55 guides the anaphase-promoting complex/cyclosome (APC/C) in choosing the DNA repair pathway choice;Oncogene;2024-03-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP